Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Psoriasis”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Large-scale testing (Phase 3)Study completedNCT02471144
What this trial is testing

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Who this might be right for
Chronic Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)Study completedNCT00141921
What this trial is testing

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Who this might be right for
Pediatric Plaque Psoriasis
Amgen 182
Large-scale testing (Phase 3)Not Yet RecruitingNCT07791199
What this trial is testing

Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers

Who this might be right for
Systemic Lupus ErythematosusSjögren's DiseasePsoriasis+1 more
Bristol-Myers Squibb 2,300
Early research (Phase 1)Study completedNCT01563068
What this trial is testing

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 18
Early research (Phase 1)Study completedNCT05252533
What this trial is testing

Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis

Who this might be right for
Juvenile Psoriatic ArthritisPsoriasisArthritis, Juvenile
Janssen Research & Development, LLC 31
Large-scale testing (Phase 3)Study completedNCT04175613
What this trial is testing

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 160
Testing effectiveness (Phase 2)Study completedNCT04655313
What this trial is testing

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)

Who this might be right for
PsoriasisPlaque Psoriasis
Arcutis Biotherapeutics, Inc. 20
Not applicableActive Not RecruitingNCT06142357
What this trial is testing

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Who this might be right for
Moderate-to-severe Plaque Psoriasis
Novartis Pharmaceuticals 199
Early research (Phase 1)Study completedNCT01582932
What this trial is testing

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 36
Large-scale testing (Phase 3)Study completedNCT00078819
What this trial is testing

Etanercept (Enbrel®) in Psoriasis - Pediatrics

Who this might be right for
Psoriasis
Amgen 211
Large-scale testing (Phase 3)Active Not RecruitingNCT03451851
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 120
Large-scale testing (Phase 3)UnknownNCT01011621
What this trial is testing

Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis

Who this might be right for
Dermatitis, AtopicDermatitis, ContactDermatitis, Seborrheic+1 more
Mantecorp Industria Quimica e Farmaceutica Ltd. 170
Large-scale testing (Phase 3)Study completedNCT02698475
What this trial is testing

An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 44
Not applicableStudy completedNCT00879944
What this trial is testing

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Who this might be right for
PsoriasisAtopic Dermatitis
Northwestern University 409
Not applicableStudy completedNCT03768284
What this trial is testing

Genetic Analysis of Pediatric Psoriasis

Who this might be right for
Psoriasis
Northwestern University 86
Not applicableLooking for participantsNCT07243782
What this trial is testing

Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea

Who this might be right for
Hidradenitis SuppurativaPediatric Plaque PsoriasisJuvenile Idiopathic Arthritis
Novartis Pharmaceuticals 76
Not applicableLooking for participantsNCT02418442
What this trial is testing

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Who this might be right for
Rheumatic Joint Disease
Duke University 20,000
Testing effectiveness (Phase 2)Study completedNCT04746911
What this trial is testing

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Who this might be right for
PsoriasisPlaque Psoriasis
Arcutis Biotherapeutics, Inc. 10
Large-scale testing (Phase 3)Looking for participantsNCT04772079
What this trial is testing

Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bristol-Myers Squibb 153
Next Page